Report
EUR 4.00 For Business Accounts Only

JKSB: Quarterly Highlights: Hemas Holdings PLC (HHL): 1QFY20

HHL concluded 1QFY20 posting a decline in revenues (-2.3% YoY) while profits saw a sharp contraction by 199.9% (YoY) mainly due to 1) the economic slowdown seen overall in the aftermath of the Easter Sunday attacks, 2) impacts to the business mix which saw high margins segments such as FMCG been severely affected during the quarter, 3) losses in the leisure segment due to the after effects from tourism with a sharp drop in arrivals in the months of May and June and 4) overall subdued consumer environment affecting segments across the group. GP margins saw a contraction from 34.58% to 32.08% while EBIT margins were further impacted by the adoption of SLFRS 16 resulting in one off ’s totaling to Rs. 130 Mn.

 We expect a gradual pickup in economic activity with tourism arrivals gradually increasing. However, consumer segment will continue to witness sluggish market conditions in the aftermath of the April 21st attacks together with uncertainty looming around the political arena. Our revised FY20E earnings are expected to reach Rs. 2,150Mn due to sharp reductions in bottom-line in the FMCG segment along with the slowdown seen in the Leisure segment. At the current price of Rs.75.00, HHL trades at a FY20E P/E of 20.8x.

Underlying
Hemas Holdings

Provider
John Keells Stock Brokers
John Keells Stock Brokers

​•JKSB is one of 15 founding members of the Colombo Stock Exchange with roots in share trading dating back to 1896, and is a subsidiary of John Keells Holdings PLC (JKH), the largest listed entity on the Colombo Stock Exchange with a market capitalization of US$ 1.3bn.

•JKSB’s core client base is Foreign Institutional Investors, Local Institutions and HNWI’s

•JKSB has a co-branded Research tie up with CIMB and a Research Referral agreement with Credit Suisse, along with trade execution relationships with several other global and regional securities firms.

•JKSB’s trade execution partners include Credit Suisse, CIMB, Merrill Lynch, Exotix, Daiwa, Convergex, Deutsche Asia Securities and Morgan Stanley

•JKSB is a research contributor to Bloomberg on ‘KEEL’ , Thomson First Call, Reuters Knowledge and FactSet

•The JKSB Research Universe covers 72 stocks across 15 sectors, with most Research efforts focused on approximately 45 of the more liquid counters.

•The JKSB Universe constitutes 67% of total market cap and approximately 80% of turnover at the CSE.

Analysts
Dishan Leo

Other Reports on these Companies
Other Reports from John Keells Stock Brokers

ResearchPool Subscriptions

Get the most out of your insights

Get in touch